374 related articles for article (PubMed ID: 35169997)
1. Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran.
Heidari R; Farajzadeh Sheikh A; Hashemzadeh M; Farshadzadeh Z; Salmanzadeh S; Saki M
Mol Biol Rep; 2022 May; 49(5):3811-3822. PubMed ID: 35169997
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterizations of antibiotic resistance, biofilm formation, and virulence determinants of Pseudomonas aeruginosa isolated from burn wound infection.
Ghasemian S; Karami-Zarandi M; Heidari H; Khoshnood S; Kouhsari E; Ghafourian S; Maleki A; Kazemian H
J Clin Lab Anal; 2023 Apr; 37(4):e24850. PubMed ID: 36808649
[TBL] [Abstract][Full Text] [Related]
3. Co-harboring of mcr-1 and β-lactamase genes in Pseudomonas aeruginosa by high-resolution melting curve analysis (HRMA): Molecular typing of superbug strains in bloodstream infections (BSI).
Tahmasebi H; Dehbashi S; Arabestani MR
Infect Genet Evol; 2020 Nov; 85():104518. PubMed ID: 32891877
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
Mohanty S; Maurya V; Gaind R; Deb M
J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology and carbapenem resistance of
Khalili Y; Memar MY; Farajnia S; Adibkia K; Kafil HS; Ghotaslou R
J Wound Care; 2021 Feb; 30(2):135-141. PubMed ID: 33573489
[TBL] [Abstract][Full Text] [Related]
7. Nationwide genome surveillance of carbapenem-resistant
Yano H; Hayashi W; Kawakami S; Aoki S; Anzai E; Zuo H; Kitamura N; Hirabayashi A; Kajihara T; Kayama S; Sugawara Y; Yahara K; Sugai M
Antimicrob Agents Chemother; 2024 May; 68(5):e0166923. PubMed ID: 38564665
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa Isolates from United States Medical Centers Stratified by Infection Type: Results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015-2016.
Sader HS; Castanheira M; Duncan LR; Flamm RK
Diagn Microbiol Infect Dis; 2018 Sep; 92(1):69-74. PubMed ID: 29789189
[TBL] [Abstract][Full Text] [Related]
9. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
Wi YM; Greenwood-Quaintance KE; Schuetz AN; Ko KS; Peck KR; Song JH; Patel R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
[TBL] [Abstract][Full Text] [Related]
10. Investigation of antimicrobial resistance patterns and molecular typing of Pseudomonas aeruginosa isolates among Coronavirus disease-19 patients.
Shiralizadeh S; Keramat F; Hashemi SH; Majzoobi MM; Azimzadeh M; Alikhani MS; Karami P; Rahimi Z; Alikhani MY
BMC Microbiol; 2023 Mar; 23(1):84. PubMed ID: 36991311
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Susceptibility Profiles To Predict the Presence of Carbapenemase Genes among Carbapenem-Resistant Pseudomonas aeruginosa Isolates.
Vallabhaneni S; Huang JY; Grass JE; Bhatnagar A; Sabour S; Lutgring JD; Campbell D; Karlsson M; Kallen AJ; Nazarian E; Snavely EA; Morris S; Wang C; Lee R; Koag M; Lewis R; Garcia B; ; Brown AC; Walters MS
J Clin Microbiol; 2021 May; 59(6):. PubMed ID: 33762362
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of biofilm phenotypic and genotypic characteristics among clinical isolates of Pseudomonas aeruginosa in Hamadan, West of Iran.
Hemmati J; Nazari M; Ahmadi A; Bayati M; Jalili M; Taheri M; Mohammadi Y; Asghari B
J Appl Genet; 2024 Feb; 65(1):213-222. PubMed ID: 38017355
[TBL] [Abstract][Full Text] [Related]
14. Association between Biofilm Formation and Antimicrobial Resistance in Carbapenem-Resistant
Cho HH; Kwon KC; Kim S; Park Y; Koo SH
Ann Clin Lab Sci; 2018 May; 48(3):363-368. PubMed ID: 29970441
[TBL] [Abstract][Full Text] [Related]
15. Detection of Carbapenemase Encoding Gene and Resistance to Cefiderocol in Hospital and Community eXtensive Drug Resistance and Carbapenem-Resistant
Benzaarate I; El Otmani F; Khazaz A; Timinouni M; Bourjilat F; Bogaerts P; Huang TD; Nayme K
Foodborne Pathog Dis; 2023 Oct; 20(10):460-466. PubMed ID: 37616567
[No Abstract] [Full Text] [Related]
16. Interaction of biofilm and efflux pump in clinical isolates of carbapenem resistant P. aeruginosa.
Li XF; Shi HQ; Liang Y; Li J; Jiang B; Song GB
Eur Rev Med Pharmacol Sci; 2022 Mar; 26(5):1729-1737. PubMed ID: 35302222
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and molecular characterization of colistin resistance in Pseudomonas aeruginosa isolates: insights from a study in Ardabil hospitals.
Jafari-Ramedani S; Nazari M; Arzanlou M; Peeri-Dogaheh H; Sahebkar A; Khademi F
BMC Microbiol; 2024 May; 24(1):152. PubMed ID: 38702660
[TBL] [Abstract][Full Text] [Related]
18. Mathematical pharmacodynamic modeling for antimicrobial assessment of ceftazidime/colistin versus gentamicin/meropenem combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm.
Badawy MSEM; Elkhatib WF; Shebl RI
Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):53. PubMed ID: 37394468
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection.
Wang Y; Li C; Wang J; Bai N; Zhang H; Chi Y; Cai Y
Microbiol Spectr; 2022 Oct; 10(5):e0146822. PubMed ID: 36102678
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
